Biote Corp (BTMD)
6.01
+0.23
(+3.98%)
USD |
NASDAQ |
May 03, 16:00
6.02
+0.01
(+0.17%)
After-Hours: 20:00
Biote Enterprise Value: 234.38M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 234.38M |
| May 02, 2024 | 226.05M |
| May 01, 2024 | 221.34M |
| April 30, 2024 | 216.27M |
| April 29, 2024 | 215.19M |
| April 26, 2024 | 216.63M |
| April 25, 2024 | 218.81M |
| April 24, 2024 | 219.17M |
| April 23, 2024 | 218.45M |
| April 22, 2024 | 217.72M |
| April 19, 2024 | 217.36M |
| April 18, 2024 | 213.74M |
| April 17, 2024 | 216.63M |
| April 16, 2024 | 223.52M |
| April 15, 2024 | 230.03M |
| April 12, 2024 | 234.74M |
| April 11, 2024 | 233.66M |
| April 10, 2024 | 232.21M |
| April 09, 2024 | 236.55M |
| April 08, 2024 | 231.48M |
| April 05, 2024 | 229.67M |
| April 04, 2024 | 224.96M |
| April 03, 2024 | 230.40M |
| April 02, 2024 | 225.69M |
| April 01, 2024 | 223.88M |
| Date | Value |
|---|---|
| March 28, 2024 | 223.86M |
| March 27, 2024 | 226.36M |
| March 26, 2024 | 227.43M |
| March 25, 2024 | 231.72M |
| March 22, 2024 | 241.72M |
| March 21, 2024 | 240.29M |
| March 20, 2024 | 245.29M |
| March 19, 2024 | 244.57M |
| March 18, 2024 | 254.57M |
| March 15, 2024 | 263.50M |
| March 14, 2024 | 238.50M |
| March 13, 2024 | 234.22M |
| March 12, 2024 | 206.01M |
| March 11, 2024 | 211.00M |
| March 08, 2024 | 209.93M |
| March 07, 2024 | 223.29M |
| March 06, 2024 | 213.01M |
| March 05, 2024 | 211.64M |
| March 04, 2024 | 205.47M |
| March 01, 2024 | 216.78M |
| February 29, 2024 | 220.55M |
| February 28, 2024 | 218.49M |
| February 27, 2024 | 230.82M |
| February 26, 2024 | 208.21M |
| February 23, 2024 | 223.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Aug 22 2022
263.50M
Maximum
Mar 15 2024
106.74M
Average
107.40M
Median
Apr 27 2023
Enterprise Value Benchmarks
| Teladoc Health Inc | 2.609B |
| American Shared Hospital Services | 26.35M |
| Novo Integrated Sciences Inc | 12.29M |
| Astrana Health Inc | 1.458B |
| Cryo-Cell International Inc | 81.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.734M |
| Revenue (Quarterly) | 45.70M |
| Total Expenses (Quarterly) | 40.20M |
| EPS Diluted (Quarterly) | 0.18 |
| Gross Profit Margin (Quarterly) | 69.36% |
| Profit Margin (Quarterly) | 16.92% |
| Earnings Yield | -3.66% |
| Operating Earnings Yield | 18.44% |
| Normalized Earnings Yield | 18.21 |